Rutgers University Study of the Genetics of Pulmonary Hypertension
Part of paid clinical trials in Piscataway, New Jersey.
- Sponsor
- Rutgers, The State University of New Jersey
- Study ID
- NCT07217522
- Status
- Recruiting
Conditions
- Pulmonary Arterial Hypertension
- Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
- Pulmonary Arterial Hypertension Associated With Connective Tissue Disease
- Pulmonary Arterial Hypertension Associated With Connective Tissue Disease (Disorder)
- Pulmonary Arterial Hypertension Associated With Schistosomiasis (Disorder)
- Pulmonary Arterial Hypertension of Congenital Heart Disease
- Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension
- Pulmonary Hypertension
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Saliva sample — GENETICSaliva sample is sent via prepaid US Mail for DNA extraction
- Health surveys — OTHERHealth surveys are filled out online in the study portal.
Study Details
The goal of this observational study is to learn more about how genes impact the risk of pulmonary hypertension. Anyone 18 or older living in the US is eligible, and a diagnosis of PH is NOT required. Study participation is online, and it takes about 20 minutes to complete health surveys and request a saliva collection kit sent through US mail. In return, study participants may opt to receive information about their genetic ancestry at no cost.
Key Dates
- Start date
- Aug 23, 2025
- Status verified
- Oct 2025
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 10,000 participants (estimated)
Arms
- Arm: Pulmonary hypertension casesStudy participants who have been diagnosed with any form of pulmonary hypertension, either currently or in the past.
- Arm: Pulmonary hypertension controlsStudy participants who have not been diagnosed with any form of pulmonary hypertension, either currently or in the past.
Primary Outcome Measure
Genetic risk variants associated with pulmonary hypertension [ Time Frame: 2 years ]
Central Contacts
- Tara Matise, Ph.D.848-445-3125
- Steve Buyske, Ph.D.
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Rutgers University, Piscataway, New Jersey 08854 | Piscataway | New Jersey | 08854 | Tara Matise, Ph.D. (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Piscataway, NJ
By research site
Related Studies
- DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)Recruiting · United Therapeutics · Birmingham, Alabama
- Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart FailureRecruiting · Abbott Medical Devices · Phoenix, Arizona
- Investigation of Dysynchrony in Patients With Pulmonary HypertensionEnrolling By Invitation · Stanford University · Stanford, California
- Spironolactone for Pulmonary Arterial HypertensionPHASE2 · Recruiting · National Institutes of Health Clinical Center (CC) · Bethesda, Maryland